菲洛病毒疫苗作为新兴传染病的应对模式
Andrea Marzi1, Heinz Feldmann2
1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, MT, USA. marzia@niaid.nih.gov.
NPJ vaccines
|October 11, 2024
概括
菲洛病毒疫苗的开发显示出对新出现的疾病的希望. 虽然埃博拉病毒病 (EVD) 的应对措施取得了成功,但对其他威胁公众健康的细菌病毒还需要进一步研究.
科学领域:
- 病毒学 病毒学
- 疫苗学 疫苗学 疫苗学
- 公共卫生 公共卫生
背景情况:
- 菲洛病毒疫苗开发取得了显著的进展,这是西非埃博拉病毒病 (EVD) 流行病所推动的.
- 获得许可的疫苗和治疗药物已被证明有效控制中非的埃博拉病毒爆发.
- 然而,在撒哈拉以南非洲地区,其他致病性filoviruses对公共卫生的威胁需要扩大对策的开发.
研究的目的:
- 在临床前和临床开发中审查当前的菲洛病毒疫苗.
- 要突出最近在EVD之外的filovirus对策研究的进展.
主要方法:
- 关于菲洛病毒疫苗的临床前研究的审查.
- 对菲洛病毒疫苗的人类临床试验的分析.
- 综合最近关于filovirus对抗措施进展的科学文献.
主要成果:
- 几种filovirus候选疫苗在临床前和临床研究中显示出有希望.
- 成功控制EVD表明了快速开发疫苗的潜力.
- 菲洛病毒疫苗研究的进展超越了EVD,解决了更广泛的公共卫生威胁.
结论:
- 菲洛病毒疫苗开发是应对新出现的传染病的关键范式.
- 对于全球卫生安全而言,对菲洛病毒对策的持续投资至关重要.
- 菲洛病毒疫苗技术的进步为控制未来疫情提供了希望.
相关概念视频
Vaccinations
44.1K
Overview
44.1K
Immune Response Against Viral Pathogens
759
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
759
Microorganisms in Medicine and Therapeutics
2
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
2
Cross-reactivity
31.0K
Overview
31.0K
Viral Recombination
23.3K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.3K


